Navigation Links
Progression in Medical News

Immune Response May Speed AIDS Progression in Women

More research needed to determine how gender affects body's reaction to HIV MONDAY, July 13 (HealthDay News) -- Differences in immune response may explain why HIV infection progresses faster to AIDS in women than in men with similar viral loads, U.S. researchers say. Their study fou...

Vaccine slows progression of skeletal muscle disorder

Irvine, Calif., May 13, 2009 A potential vaccine for Alzheimer's disease also has been shown in mice to slow the weakening of muscles associated with inclusion body myositis, a disorder that affects the elderly. The finding brings new hope for IBM patients with weakness, inflammation or atroph...

Glutamate Identified As Predictor of Disease Progression in Multiple Sclerosis

UCSF researchers have identified a correlation between higher levels of glutamate, which occurs naturally in the brain as a byproduct of metabolism, and greater disease burden in multiple sclerosis patients. (Vocus) April 30, 2009 -- UCSF researchers have identified a c...

Avastin effective at delaying brain tumor progression in recurrent disease

(SEATTLE) The use of Avastin alone to treat a subgroup of recurrent Grade 3 brain tumors showed it was safe and effective at delaying tumor progression, according to a retrospective study of 22 patients conducted by a researcher at the Seattle Cancer Care Alliance. The patients all had a recurr...

Drug Fails to Slow Progression of Atherosclerosis

Pactimibe also was associated with more risk of major heart problems, study finds TUESDAY, March 17 (HealthDay News) -- A drug that blocks an enzyme involved in the accumulation of cholesterol does not reduce the progression of atherosclerosis, thickening and stiffening of the arterie...

Chondroitin slows progression and relieves symptoms of knee osteoarthritis

Osteoarthritis (OA) causes disability and is a major public health problem. A new study examined the effect of chondroitins 4 and 6 sulfate (CS) on OA progression and symptoms. CS, unlike other chondroitin sulfate products sold as dietary supplements in the U.S., has been approved as a prescriptio...

More>>

Progression in Medical Technology

Proteolix, Inc. Drug Candidate, PR-957, Prevents Disease Progression in Rheumatoid Arthritis Models by Selective Inhibition of the Immunoproteasome

Findings Published in Nature Medicine Suggest Broad Implications for the Treatment of Inflammatory and Autoimmune Disorders SOUTH SAN FRANCISCO, Calif., June 15 /PRNewswire/ -- Proteolix, Inc. announced that in an article published today in Nature Medicine, Proteolix's selective immunoprote...

Data Demonstrated ACTEMRA(R) (tocilizumab) Significantly Inhibited Progression of Structural Joint Damage in Rheumatoid Arthritis Patients

- Additional data reinforce long-term efficacy of ACTEMRA across a broad range of rheumatoid arthritis patient populations - NUTLEY, N.J., June 9 /PRNewswire/ -- One-year data from the two-year Phase III LITHE (Toci LI zumab Safety and THE Prevention of Structural Joint Damage) study de...

Two-Year Data Reinforce Effect of ACTEMRA(R) (tocilizumab) in Inhibiting Progression of Joint Damage and Improving Physical Function in Rheumatoid Arthritis Patients

- Fifth International Phase III ACTEMRA Study Meets its Primary Endpoints - NUTLEY, N.J., May 25 /PRNewswire/ -- Roche today announced that two-year data from the LITHE (Toci LI zumab Safety and THE Prevention of Structural Joint Damage) study demonstrated that ACTEMRA(R) (tocilizumab...

Study Finds DOXIL(R) Combination Therapy Delays Disease Progression for Patients With Metastatic Breast Cancer

SAN ANTONIO, Dec. 14 /PRNewswire/ -- Results from a Phase 3 study show that patients with metastatic breast cancer who were treated previously with an anthracycline in the adjuvant setting experienced a significant improvement in time to disease progression (TTP) and overall response rates after r...

New Study Demonstrated ACTEMRA(R) (tocilizumab) Inhibited Progression of Joint Damage in Rheumatoid Arthritis Patients

- One-year study results showed improved physical function in patients treated with ACTEMRA - NUTLEY, N.J., Oct. 25 /PRNewswire/ -- One-year data from a two-year Phase III study demonstrated that ACTEMRA(R) (tocilizumab) significantly inhibited the progression of structural joint damage in p...

Five-Year Data Confirm That Early Treatment with Betaseron(R) at First Sign of Disease Can Delay Progression to MS

- BENEFIT is first and only prospectively planned 5-year study to show long lasting benefit of early treatment - MONTREAL, Sept. 20 /PRNewswire/ -- Bayer HealthCare Pharmaceuticals announced today that new data from its BENEFIT (BEtaseron in Newly Emerging multiple sclerosis For...

More>>

Progression in Medical Products

Humphrey GPA Glaucoma Progression Analysys Software

Description: Only Humphrey GPA software accurately differentiates clinically significant progression of visual field loss from random variability, providing an advanced, proven method to enhance management of glaucoma for your patients. The software applies knowledge acquired from a multi-center clinical tri...
Company:Carl Zeiss Meditec, Inc.

Macula Complete

Description:...cula Complete includes the nutrients used in the ARED study, as well as the Lutein Antioxidant Supplement Trial (LAST), which suggested no AMD disease progression in the study participants in a one year period. Macula Complete also contains efficacious amounts of nutrients suggested in peer-reviewed studies to s...
Company:Biosyntrx, Inc.

Ocuvite® PreserVision® Tablets AREDS formula

Description:... by the National Eye Institute (a division of the National Institutes of Health) showed that a unique vitamin and mineral supplement may help slow the progression of age-related macular degeneration and its associated vision loss among patients most at risk....
Company:Bausch & Lomb, Inc.

PreView PHP (Preferential Hyperacuity Perimetry)

Description:...set neovascular ("wet") age-related macular degeneration (AMD). This macular perimeter maps and quantifies visual field defects consistent with the progression of intermediate ("dry") AMD to the wet stage of the disease. By overcoming the brain's ability to compensate for small visual field defects, the PreVi...
Company:Carl Zeiss Meditec, Inc.

Liquichek Seroconversion Panels

Description:... Each Liquichek Seroconversion Panel features a series of serum specimens drawn over time from one individual to show the progression from a negative to a positive disease state....
Company:Bio-Rad Laboratories

The BTA TRAK® Assay

Description:... A Powerful New Quantitative Immunoassay for Monitoring Bladder Cancer Patients. Useful in Monitoring Patients for Disease progression and Recurrence....
Company:Polymedco Inc.
Progression in Medical Definition

Pathology

...sia , and oncology ( C00-D48 ) Benign tumors Hyperplastic tumor - Cyst - Pseudocyst - Hamartoma - Benign neoplasm Malignant progression Dysplasia - Carcinoma in situ - Invasive cancer - Metastasis Topography Anus - Bladder - Bile duct - Bone - Brain - Breas...

Ocular oncology

...sia , and oncology ( C00-D48 ) Benign tumors Hyperplastic tumor - Cyst - Pseudocyst - Hamartoma - Benign neoplasm Malignant progression Dysplasia - Carcinoma in situ - Invasive cancer - Metastasis Topography Anus - Bladder - Bile duct - Bone - Brain - Breas...
Progression in Medical Dictionary

Superinfection

... C Drug induced superinfection in HIV and the evolution of drug resistance. ... HIV Type 1 Superinfection with a Dual-Tropic Virus and Rapid progression to AIDS: ... determining the prevalence of superinfection . ... Biologically, superinfection is the sequential ... Superinfection could als...

Silicosis

...ational pulmonary disease, is caused by ... Silicosis is the oldest known environmental lung disease. ... Silicosis cannot be cured, but its progression can be slowed if exposure to ... Offers details of those at risk, treatment, prevention, resources, and more. ...

Sigmoid

...ent it is liable to be displaced into the abdominal cavity. Many natural processes and complex system learning curves display a history dependent progression from small beginnings that accelerates and approaches a climax over time. For lack of... SIGMOID works at the interface of these two areas. ... ...

Retinitis pigmentosa

... Retinitis pigmentosa (RP) is a group of genetic eye conditions. In the progression of symptoms for RP, night blindness generally precedes tunnel vision by years or even decades. Many people with RP do not become legally blind... ...

Retinitis

...ved from "http://en.wikipedia.org /wiki/ Retinitis " ... Retinitis pigmentosa (RP) is a group of genetic eye conditions. In the progression of symptoms for RP, night blindness generally precedes tunnel vision by years or even decades. Many people with RP do not become legally blind... ...

Pulmonary Diseases

...ry disease caused by inhaling asbestos fibers ... ... are lacking for RB-ILD (as opposed to other smoking-related pulmonary diseases ) ... progression of the disease to advanced pulmonary fibrosis and death are ... Detailed information on respiratory disorders, including causes, symptoms,...
Progression in Biological News

Drug prevents seizure progression in model of epilepsy

PITTSBURGHCarnegie Mellon University researchers have identified a new anticonvulsant compound that has the potential to stop the development of epilepsy. The findings are published in the March issue of the journal Epilepsia . The research discovery builds on previous work identifying a sp...

Epstein-Barr virus may be associated with progression of MS

BUFFALO, N.Y. -- Epstein-Barr virus (EBV), the pathogen that causes mononucleosis, appears to play a role in the neurodegeneration that occurs in persons with multiple sclerosis, researchers at the University at Buffalo and the University of Trieste, Italy, have shown. Multiple sclerosis (MS) ...

Researchers identify gene linked to aggressive progression of liver cancer

RICHMOND, Va. (Feb. 17, 2009) Virginia Commonwealth University researchers have identified a gene that plays a key role in regulating liver cancer progression, a discovery that could one day lead to new targeted therapeutic strategies to fight the highly aggressive disease. Hepatocellular carc...

Gene therapy slows progression of fatal neurodegenerative disease in children

New Rochelle, NY, May 13, 2008Gene therapy to replace the faulty CLN2 gene, which causes a neurodegenerative disease that is fatal by age 8-12 years, was able to slow significantly the rate of neurologic decline in treated children, according to a paper published online ahead of print in the May 2...

Study begins to reveal clues to the cause and progression of sepsis

PITTSBURGH, Aug. 13 Not all patients with sepsis mount the same immune response, even when they look the same clinically, according to findings from the first large-scale natural history study of sepsis. The results, published by University of Pittsburgh School of Medicine researchers in the Augu...

Green tea may affect prostate cancer progression

PHILADELPHIA According to results of a study published in Cancer Prevention Research , a journal of the American Association for Cancer Research, men with prostate cancer who consumed the active compounds in green tea demonstrated a significant reduction in serum markers predictive of prostate c...
Progression in Biological Technology

Pixantrone Significantly Increases Complete Remissions, Overall Response Rates, Frequency of Durable Remissions and Progression Free Survival in Patients with Relapsed and Refractory Aggressive Non-Hodgkin's Lymphoma

First Randomized Trial to Demonstrate Superior Clinical Benefit in Relapsed/Refractory Aggressive NHL ORLANDO, Fla., June 1 /PRNewswire-FirstCall/ -- Intent to treat Analysis results per FDA agreed upon Statistical Analysis Plan Significant Increase in Complete Rem...

Flurizan's Effect in Delaying Progression From Mild Cognitive Impairment to Alzheimer's Disease is Superior to That of Aricept

Following its Launch in 2010, Myriad Genetics' Flurizan Will Earn a 23% Patient Share in the United States, According to a New Report from Decision Resources WALTHAM, Mass., Feb. 5 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisor...

Discovery may halt progression of Alzheimer's

Jeff Johnson Source: School of Pharmacy @ UW - Madison In a finding that may cause a dramatic shift in the way scientists and researchers search for a therapy for Alzheimer's disease, a team of researchers led by Jeff Johnson , an associate professor at the School of Pharmacy , has discovere...

NeurogesX Reports Second Quarter 2009 Results

...arter of 2009 was our most significant three-month period to date. With the marketing authorization of Qutenza in Europe we significantly advanced our progression into a commercial company while finalizing our partnership with Astellas fulfilled an important part of our global commercialization strategy by provi...

Repligen Reports First Quarter Fiscal Year 2010 Financial Results

...reclinical studies have shown that specific HDAC inhibitors increase production of the protein frataxin which may have the potential to arrest disease progression in patients with Friedreich's ataxia. We have identified several potential clinical candidates and are further characterizing these leads in preclini...

Oncothyreon announces presentation of long-term Stimuvax data at World Conference on Lung Cancer

...our patients had stable disease. The remaining six of the 16 patients discontinued Stimuvax after 2.0 to 5.1 years of treatment as a result of disease progression and are deceased. Prolonged treatment with Stimuvax was well-tolerated in this trial. The most common treatment-related adverse events were injectio...
Progression in Biological Products

microPET Focus 120 from CTI Molecular Imaging, Inc.

Description:...the same animal. This gives the researchers the opportunity to follow a single animal over time and to monitor the effects of interventions on disease progression and outcome. microPET is therefore a particularly valuable tool in animal models that have high intrinsic value or which exhibit high variability. ...
Company:CTI Molecular Imaging, Inc.

microPET R4 from CTI Molecular Imaging, Inc.

Description:...the same animal. This gives the researchers the opportunity to follow a single animal over time and to monitor the effects of interventions on disease progression and outcome. microPET is therefore a particularly valuable tool in animal models that have high intrinsic value or which exhibit high variability. ...
Company:CTI Molecular Imaging, Inc.

microPET Focus 220 from CTI Molecular Imaging, Inc.

Description:...the same animal. This gives the researchers the opportunity to follow a single animal over time and to monitor the effects of interventions on disease progression and outcome. microPET is therefore a particularly valuable tool in animal models that have high intrinsic value or which exhibit high variability. ...
Company:CTI Molecular Imaging, Inc.

Anti-Cyclin D2 (G1-phase Cyclin) Ab-2 Monoclonal Antibody, Unconjugated from Lab Vision

Description:... Cyclin D2 is a G1 cyclin required for G1-phase progression and is a strong candidate for a proto-oncogene. cyclin D2 can phosphorylate pRB when associated with cdk4 and/or cdk6. Species Reactivity: Human, Mo...
Company:Lab Vision

ProteinChip beta-amyloid multipeptide detection Kit from Ciphergen

Description:...nical neuroscience proteomics applications - Monitor beta-amyloid expression after drug treatment - Correlate beta-amyloid peptide levels with disease progression - Evaluate mechanisms of Alzheimers disease pathogenesis...
Company:Ciphergen

Anti-JIP 1 / 2 (SH3) Polyclonal Antibody, Unconjugated, Clone ZMD.177 from Invitrogen

Description:...zheimers disease patients, this evidence suggests that the JNK signaling pathway, and thus the scaffolding function of JIP1, may be fundamental to the progression of Alzheimers disease....
Company:Invitrogen
Progression in Biological Definition

Diabetes mellitus

... References Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-86. Fulltext . PMID 8366922 . World Health Orga...

Evolutionary tree

...ld follow the tree whenever possible, but in many places it does not at present. The description as a "tree" results from earlier ideas of life as a progression from lower to higher forms. Although such views are discredited now, the imagery is too well established to be readily lost. The terminology origina...

Golgi apparatus

... medial region towards the trans face and are modified on their way. The transport mechanism itself is not yet clear; it could happen by cisternae progression (the movement of the apparatus itself, building new cisternae at the cis face and destroying them at the trans face) or by vesicular transport (sma...
Progression in Biological Dictionary

Viral oncogene

...molog. KRAS1. KRAS2 ... ... leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) ... oncogene ; ovarian ; progression ; protein ; proto- oncogene ; ... Human protein-coding gene MYB. Represented by 97 ESTs from 52 ... Homo sapiens c-myb gene for v-myb myelob...

Vascular plants

... generation phase is the large, dominant, ... Vascular plants show a progression of increasing sporophyte dominance from the ... The vascular plants h...eared by 350 million years ago, with forests ... Vascular plants show a progression of increasing sporophyte dominance from the ... Provides links to USGS...

Telomere

... Telomere shortening. ... Identification of a specific telomere terminal transferase activity in Tetrahymena extracts" ... Telomere length and progression of diabetic nephropathy in patients with type 1 diabetes. ... Telomere dysfunction provokes regional amplification and deletion ... Negative ...

Replication fork

...site direction. ... In cells, replication forks proceed slowly throughout chromatin, rather than ... Mrc1 and Tof1 Promote Replication Fork progression and Recovery Independently of ... Several enzymes at the replication fork are essential to the synthesis of both strands. ... Eventually, the...

Microtubules

...ovides an accessible introduction for undergraduate or medical students who are taking a first course on cell ... This book is concerned with the progression from molecules to multicellular organisms. ... The microtubules in six specialized touch-sensitive neurons in the nematode ... With respect to m...

Gene expression

..., microarrays. TissueScan qPCR Arrays, Disease Panels for gene expression , Biomarker validation and SNP analsysis across many stages of Disease progression from high quality, ... Gene Expression . NEW! SGC Expression Clones. cDNAs, ORFs, Promoters. Yeast Strains ... Human Full-Length Expression ...
Other Tags
(Date:7/9/2014)... for more than watching World Cup highlights, Brian Williams ... landing in unfortunate positions on railings. A University of ... Online Journal shows that YouTube also allows researchers, ... public on topics of skin cancer and prevention. , ... the future of how we communicate around the world," ...
(Date:7/9/2014)... Infectious Diseases (NIAID), part of the National Institutes ... of CRS3123, an investigational oral antibiotic intended to ... ) infection. CRS3123 (previously known as REP3123) is ... while sparing normal intestinal bacteria. , The Phase ... men and women ages 18 to 45 in ...
(Date:7/9/2014)... A retrospective study conducted by researchers at Tufts ... among adults with intellectual and developmental disabilities, the likelihood ... receiving dental care increased. The findings, published in the ... may help improve interventions designed to address the oral ... researchers reviewed the dental records of 107 patients at ...
(Date:7/9/2014)... older age with kidney and heart disease have raised ... older adults. However, in the first study to look ... of Medicine at the University of Pennsylvania report that ... life expectancy and cardiovascular health as very healthy older ... of the ever increasing organ transplant waitlists, the authors ...
(Date:7/9/2014)... published in the scientific journal Nature Neuroscience ... at Universit Laval, reveals that it is possible to ... rekindling pain so that it can subsequently be erased. ... chronic pain. , The researchers from the Faculty of ... mentale de Qubec (IUSMQ) were inspired by previous work ...
Breaking Medicine News(10 mins):Health News:Study of dermatology on YouTube shows new ways science reaches public 2Health News:NIH launches Phase I clinical trial of novel drug to treat Clostridium difficile infection 2Health News:Adults with special needs see gains, challenges with long term oral care 2Health News:Adults with special needs see gains, challenges with long term oral care 3Health News:Penn study finds living kidney donation does not increase risk of death or heart disease for older 2Health News:Discovery of a new means to erase pain 2
(Date:7/9/2014)... announce themselves with pain and fever but often can be ... are sneaky and hard to beat. Now, scientists have built ... tiny DNA pyramids. Published in the journal ACS Applied ... flag bacteria and kill more of them than medicine alone. ... infectious pathogens can lie in wait, undetectable in the human ...
(Date:7/9/2014)... developed by researchers at the NIH,s National ... its collaborators to treat sickle cell disease ... business. The drug candidate, Aes-103, is the ... molecular mechanism of sickle cell disease. Baxter ... required for regulatory approval and commercialization. , ...
(Date:7/9/2014)... cancer patients with high levels of vitamin D in their ... shows. , Patients with the highest levels of vitamin ... with the lowest levels, the findings reveal. , The study ... D in bowel cancer patients after their diagnosis which ... from dietary sources with their long term survival prospects. ...
Breaking Biology News(10 mins):First drug candidate from NIH program acquired by biopharmaceutical company 2First drug candidate from NIH program acquired by biopharmaceutical company 3First drug candidate from NIH program acquired by biopharmaceutical company 4
Other Contents